Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy

被引:29
作者
Foa, Alberto [1 ]
Agostini, Valentina [2 ]
Rapezzi, Claudio [1 ]
Olivotto, Iacopo [3 ]
Corti, Barbara [2 ]
Potena, Luciano [4 ]
Biagini, Elena [1 ]
Suarez, Sofia Martin [4 ]
Rotellini, Matteo [5 ]
Cecchi, Franco [5 ]
Stefano, Pierluigi [5 ]
Coppini, Raffaele [6 ]
Ferrantini, Cecilia [5 ]
Reggiani, Maria L. Bacchi [1 ]
Leone, Ornella [2 ]
机构
[1] Alma Mater Studiorum Univ Bologna, Dept Expt Diagnost & Specialty Med, Cardiol, Via G Massarenti 9, I-40138 Bologna, Italy
[2] St Orsola Malpighi Univ Hosp, Dept Pathol, Cardiovasc Pathol Unit, Bologna, Italy
[3] Careggi Univ Hosp, Cardiomyopathy Unit, Florence, Italy
[4] St Orsola Malpighi Univ Hosp, Heart Transplant Program, Bologna, Italy
[5] Careggi Univ Hosp, Cardiothorac & Vasc Dept, Florence, Italy
[6] Univ Florence, Dept NeuroFarBa, Florence, Italy
关键词
Hypertrophic cardiomyopathy; Histopathology; Myocardial fibrosis; Vascular remodeling; MICROVASCULAR DYSFUNCTION; MANAGEMENT; DISEASE;
D O I
10.1016/j.ijcard.2019.03.060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Although imaging techniques have demonstrated the existence of microvascular abnormalities in hypertrophic cardiomyopathy (HCM), a detailed histopathological assessment is lacking as well as a comparison between different phases of the disease. We aimed to compare microvasculopathy and myocardial fibrosis in hypertrophic obstructive cardiomyopathy (HOCM) versus end-stage (ES) HCM. Methods: 27 myectomy specimens of HOCM patients and 30 ES-HCM explanted hearts were analyzed. Myocardial fibrosis was quantitatively determined with dedicated software and qualitatively classified as scar-like or interstitial. Intramural coronary arteries were evaluated separately according to lumen diameter: 100-500 mu versus <100 mu. Microvasculopathy assessment included the description of medial and intimal abnormalities and stenosis grading. The two subgroups were compared considering only the anterobasal septum of ES explanted hearts. Results: Median value of fibrosis in the anterobasal septum of explanted hearts was 34.6% as opposed to 10.3% of myectomy specimens (p < 0.001). Scar-like fibrosis was widely found in ES hearts while interstitial fibrosis was distinctive of HOCM (p < 0.001). All slides showed 100-500 mu microvasculopathy without any differences between subgroups in terms of lumen narrowing, extent of the disease and type of parietal involvement. Among ES hearts these lesions were associated with scar-like fibrosis (p = 0.034). <100-mu microvasculopathy was also frequent with no differences between subgroups. Conclusions: Microvasculopathy is an intrinsic feature of HCM with similar characteristics across the natural phases of the disease. Conversely, myocardial fibrosis changes over time with ES hearts showing a three-fold greater amount, mainly scar-like. ES showed a closer association between microvasculopathy and replacement fibrosis. (C) 2019 The Authors. Published by Elsevier B.V.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 16 条
[1]  
Burke A, 2001, PRACTICAL CARDIOVASC, P158
[2]   Medical progress - Coronary microvascular dysfunction [J].
Camici, Paolo G. ;
Crea, Filippo .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :830-840
[3]   The embryological basis of subclinical hypertrophic cardiomyopathy [J].
Captur, Gabriella ;
Ho, Carolyn Y. ;
Schlossarek, Saskia ;
Kerwin, Janet ;
Mirabel, Mariana ;
Wilson, Robert ;
Rosmini, Stefania ;
Obianyo, Chinwe ;
Reant, Patricia ;
Bassett, Paul ;
Cook, Andrew C. ;
Lindsay, Susan ;
McKenna, William J. ;
Mills, Kevin ;
Elliott, Perry M. ;
Mohun, Timothy J. ;
Carrier, Lucie ;
Moon, James C. .
SCIENTIFIC REPORTS, 2016, 6
[4]   Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy [J].
Cecchi, F ;
Olivotto, I ;
Gistri, R ;
Lorenzoni, R ;
Chiriatti, G ;
Camici, PG .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (11) :1027-1035
[5]   2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J].
Elliott, Perry M. ;
Anastasakis, Aris ;
Borger, Michael A. ;
Borggrefe, Martin ;
Cecchi, Franco ;
Charron, Philippe ;
Hagege, Albert Alain ;
Lafont, Antoine ;
Limongelli, Giuseppe ;
Mahrholdt, Heiko ;
McKenna, William J. ;
Mogensen, Jens ;
Nihoyannopoulos, Petros ;
Nistri, Stefano ;
Pieper, Petronella G. ;
Pieske, Burkert ;
Rapezzi, Claudio ;
Rutten, Frans H. ;
Tillmanns, Christoph ;
Watkins, Hugh .
EUROPEAN HEART JOURNAL, 2014, 35 (39) :2733-+
[6]   Histological and Histometric Characterization of Myocardial Fibrosis in End-Stage Hypertrophic Cardiomyopathy: A Clinical-Pathological Study of 30 Explanted Hearts [J].
Galati, Giuseppe ;
Leone, Ornella ;
Pasquale, Ferdinando ;
Olivotto, Iacopo ;
Biagini, Elena ;
Grigioni, Francesco ;
Pilato, Emanuele ;
Lorenzini, Massimiliano ;
Corti, Barbara ;
Foa, Alberto ;
Agostini, Valentina ;
Cecchi, Franco ;
Rapezzi, Claudio .
CIRCULATION-HEART FAILURE, 2016, 9 (09)
[7]   Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe) [J].
Ho, Carolyn Y. ;
Day, Sharlene M. ;
Ashley, Euan A. ;
Michels, Michelle ;
Pereira, Alexandre C. ;
Jacoby, Daniel ;
Cirino, Allison L. ;
Fox, Jonathan C. ;
Lakdawala, Neal K. ;
Ware, James S. ;
Caleshu, Colleen A. ;
Helms, Adam S. ;
Colan, Steven D. ;
Girolami, Francesca ;
Cecchi, Franco ;
Seidman, Christine E. ;
Sajeev, Gautam ;
Signorovitch, James ;
Green, Eric M. ;
Olivotto, Iacopo .
CIRCULATION, 2018, 138 (14) :1387-1398
[8]   The pathology of hypertrophic cardiomyopathy [J].
Hughes, SE .
HISTOPATHOLOGY, 2004, 44 (05) :412-427
[9]   Clinical Course and Management of Hypertrophic Cardiomyopathy [J].
Maron, Barry J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (07) :655-668
[10]   INTRAMURAL (SMALL VESSEL) CORONARY-ARTERY DISEASE IN HYPERTROPHIC CARDIOMYOPATHY [J].
MARON, BJ ;
WOLFSON, JK ;
EPSTEIN, SE ;
ROBERTS, WC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (03) :545-557